India's Ranbaxy To Sell Daiichi Sankyo's Tavanic In S. Africa, Romania
This article was originally published in PharmAsia News
Executive Summary
India's Ranbaxy Laboratories says it plans to market a drug for treating infections in Romania and South Africa for parent Daiichi Sankyo